Market Cap : 120.79 M | Enterprise Value : 85.49 M | PE Ratio : At Loss | PB Ratio : 1.73 |
---|
NAS:STIM has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:STIM has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
This is the average share buyback rate of the company over the past 3 years. A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.
The historical rank and industry rank for Neuronetics's 3-Year Average Share Buyback Ratio or its related term are showing as below:
During the past years, Neuronetics's highest 3-Year Average Share Buyback Ratio was -4.50. The lowest was -1092.30. And the median was -14.20.
The historical data trend for Neuronetics's 3-Year Average Share Buyback Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Neuronetics's 3-Year Average Share Buyback Ratio, along with its competitors' market caps and 3-Year Average Share Buyback Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Diagnostics & Research industry and Healthcare sector, Neuronetics's 3-Year Average Share Buyback Ratio distribution charts can be found below:
* The bar in red indicates where Neuronetics's 3-Year Average Share Buyback Ratio falls into.
This is the average share buyback rate of the company over the past 3 years.
A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.
Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.
Thank you for viewing the detailed overview of Neuronetics's 3-Year Average Share Buyback Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Cannell Capital Llc | 10 percent owner | 245 MERIWETHER CIRCLE ALTA WY 83414 |
Rosengarten Megan | director | C/O NEURONETICS, INC. 3222 PHOENIXVILLE PIKE MALVERN PA 19355 |
Cascella Robert | director | C/O HOLOGIC, INC. BEDFORD MA 01730 |
Shook Bruce Joseph | director | 162 CRICKET AVE ARDMORE PA 19003 |
Jaeger Wilfred E | director | C/O THREE ARCH PARTNERS 3200 ALPINE RD PORTOLA VALLEY CA 94028 |
Bakewell John K | director | C/O LANTHEUS MEDICAL IMAGING, INC. 331 TREBLE COVE ROAD NO. BILLERICA MA 01862 |
Conley Sheryl L | director | C/O NEURONETICS, INC. 3222 PHOENIXVILLE PIKE MALVERN PA 19355 |
Muir Glenn P | director | C/O HOLOGIC, INC. BEDFORD MA 01730 |
Sullivan Keith J | director, officer: President and CEO | C/O RELIANT TECHNOLOGIES, INC. 464 ELLIS STREET MOUNTAIN VIEW CA 94043 |
Macan William Andrew | officer: Sr. VP, GC, CCO and Secretary | 24275 KATY FREEWAY, SUITE 600 KATY TX 77494 |
Harper Gregory | officer: VP of Prod. Dev. & Operations | C/O NEURONETICS, INC 3222 PHOENIXVILLE PIKE MALVERN PA 19355 |
Furlong Stephen | officer: CFO | C/O NEURONETICS, INC. 3222 PHOENIXVILLE PIKE MALVERN PA 19355 |
Tropsha Yelena | officer: VP of Commercial Access | C/O NEURONETICS, INC 3222 PHOENIXVILLE PIKE MALVERN PA 19355 |
Farley Brian E | director | 2200 ZANKER ROAD SUITE F SAN JOSE CA 95131 |
Guthrie Daniel | officer: Chief Commercial Officer | C/O NEURONETICS, INC 322 PHOENIXVILLE PIKE MALVERN PA 19355 |
From GuruFocus
Other Sources
By Zacks 2020-11-02
By Zacks 2022-03-10
By Seekingalpha 2020-11-03
By Zacks 2021-08-25
By Zacks 2021-05-04
By Zacks 2021-03-02
By Zacks 2021-03-02
By Zacks 2022-03-08
By Zacks 2022-03-09
By Zacks 2020-08-04